Prof. Dr. med. Peter Fasching

Department of Obstetrics and Gynaecology Professur für Translationale Frauenheilkunde und Geburtshilfe

Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2− Advanced Breast Cancer (2025) Sammons S, Yardley DA, Sharma P, Gadi VK, Pegram M, Pathak P, Hu H, et al. Journal article Clinical characterization of endometriosis phenotypes (2025) Hofbeck L, Au K, Blum S, Sipulina N, Lotz L, Lermann JH, Renner SP, et al. Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article Evaluation and feasibility of diagnostic heatflow imaging in patients with palpable breast lesions: a pilot study (2025) Pöschke P, Boese A, Seitz K, Amann N, Eckstein S, Schulmeyer C, Hack C, et al. Journal article A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study (2025) Hübner H, Wurmthaler L, Goossens C, Ernst M, Mocker A, Krückel A, Kallert M, et al. Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025 (2025) Thill M, Janni W, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, et al. Journal article, Review article AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025 (2025) Park-Simon TW, Müller V, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, et al. Journal article, Review article Therapy of early breast cancer: current status and perspectives (2025) Tauber N, Amann N, Dannehl D, Deutsch TM, Dimpfl M, Fasching P, Hartkopf A, et al. Journal article, Review article COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II Study (2025) Pixberg C, Maurer C, Smetanay K, Straβl L, Hlevnjak M, Zapatka M, Wagner CV, et al. Journal article Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer (2025) Lüftner D, Banys-Paluchowski M, Hartkopf AD, Hörner M, Janni W, Langanke D, Müller V, et al. Journal article